Rok Cerne

932 total citations
45 papers, 638 citations indexed

About

Rok Cerne is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Sensory Systems. According to data from OpenAlex, Rok Cerne has authored 45 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cellular and Molecular Neuroscience, 20 papers in Molecular Biology and 6 papers in Sensory Systems. Recurrent topics in Rok Cerne's work include Neuroscience and Neuropharmacology Research (27 papers), Pharmacological Receptor Mechanisms and Effects (9 papers) and Receptor Mechanisms and Signaling (8 papers). Rok Cerne is often cited by papers focused on Neuroscience and Neuropharmacology Research (27 papers), Pharmacological Receptor Mechanisms and Effects (9 papers) and Receptor Mechanisms and Signaling (8 papers). Rok Cerne collaborates with scholars based in United States, Slovenia and United Kingdom. Rok Cerne's co-authors include Jeffrey M. Witkin, Robert W. Bryant, Dennis Sprous, Jodi L. Smith, Yang Qian, James M. Cook, Lalit K. Golani, Arnold Lippa, Jeffrey M. Schkeryantz and Michael J. Krambis and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Rok Cerne

44 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rok Cerne United States	13	248	220	158	79	76	45	638
Young‐Ho Jin South Korea	16	182 0.7×	268 1.2×	74 0.5×	84 1.1×	40 0.5×	35	879
Jardel Gomes Villarinho Brazil	16	248 1.0×	167 0.8×	80 0.5×	60 0.8×	33 0.4×	19	673
Ana Carolina Rossaneis Brazil	13	94 0.4×	177 0.8×	154 1.0×	66 0.8×	28 0.4×	29	859
Masoumeh Emamghoreishi Iran	17	110 0.4×	228 1.0×	82 0.5×	68 0.9×	53 0.7×	56	1.0k
Davood Farzin Iran	13	214 0.9×	268 1.2×	36 0.2×	39 0.5×	70 0.9×	33	569
Tuane Bazanella Sampaio Brazil	15	236 1.0×	175 0.8×	39 0.2×	79 1.0×	47 0.6×	44	830
Kazuo Takahama Japan	17	268 1.1×	409 1.9×	59 0.4×	66 0.8×	41 0.5×	108	982
Malay Bhowmik India	9	86 0.3×	171 0.8×	49 0.3×	99 1.3×	24 0.3×	12	500
Brinell Arcanjo Moura Brazil	14	130 0.5×	188 0.9×	67 0.4×	41 0.5×	42 0.6×	15	828
Tasha L. Hutchinson United States	10	206 0.8×	171 0.8×	372 2.4×	95 1.2×	40 0.5×	10	671

Countries citing papers authored by Rok Cerne

Since Specialization

Citations

This map shows the geographic impact of Rok Cerne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rok Cerne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rok Cerne more than expected).

Fields of papers citing papers by Rok Cerne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rok Cerne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rok Cerne. The network helps show where Rok Cerne may publish in the future.

Co-authorship network of co-authors of Rok Cerne

This figure shows the co-authorship network connecting the top 25 collaborators of Rok Cerne. A scholar is included among the top collaborators of Rok Cerne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rok Cerne. Rok Cerne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Radin, Daniel P., Rok Cerne, Jodi L. Smith, Jeffrey M. Witkin, & Arnold Lippa. (2025). Antipsychotic-like pharmacological profile of the low impact ampakine CX691 (farampator): Implications for the use of low impact ampakines in the treatment of schizophrenia. Journal of Psychiatric Research. 186. 145–153. 1 indexed citations

Witkin, Jeffrey M., Daniel P. Radin, Sabhya Rana, et al.. (2024). AMPA receptors play an important role in the biological consequences of spinal cord injury: Implications for AMPA receptor modulators for therapeutic benefit. Biochemical Pharmacology. 228. 116302–116302. 7 indexed citations

Radin, Daniel P., Sheng Zhong, Rok Cerne, et al.. (2024). Low-Impact Ampakine CX1739 Exerts Pro-Cognitive Effects and Reverses Opiate-Induced Respiratory Depression in Rodents. SHILAP Revista de lepidopterología. 4(1). 173–187. 12 indexed citations

Radin, Daniel P., Rok Cerne, Jeffrey M. Witkin, & Arnold Lippa. (2024). High-Impact AMPAkines Elevate Calcium Levels in Cortical Astrocytes by Mobilizing Endoplasmic Reticular Calcium Stores. SHILAP Revista de lepidopterología. 5(3). 344–355. 1 indexed citations

Rana, Sabhya, Jeffrey M. Witkin, Daniel P. Radin, et al.. (2024). Pharmacological modulation of respiratory control: Ampakines as a therapeutic strategy. Pharmacology & Therapeutics. 265. 108744–108744. 3 indexed citations

Lipsky, Robert H., et al.. (2024). Traumatic brain injury: molecular biomarkers, genetics, secondary consequences, and medical management. Frontiers in Neuroscience. 18. 1446076–1446076. 3 indexed citations

Radin, Daniel P., Sheng Zhong, Rok Cerne, Jeffrey M. Witkin, & Arnold Lippa. (2024). High Impact AMPAkines Induce a Gq‐Protein Coupled Endoplasmic Calcium Release in Cortical Neurons: A Possible Mechanism for Explaining the Toxicity of High Impact AMPAkines. Synapse. 78(5). e22310–e22310. 1 indexed citations

Ping, Xingjie, Lalit K. Golani, Xiaoming Jin, et al.. (2023). Comparative anticonvulsant activity of the GABAkine KRM‐II‐81 and a deuterated analog. Drug Development Research. 84(3). 601–605. 2 indexed citations

Golani, Lalit K., Rok Cerne, Jodi L. Smith, et al.. (2022). Metabolism, pharmacokinetics, and anticonvulsant activity of a deuterated analog of the α2/3‐selective GABAkine KRM‐II‐81. Biopharmaceutics & Drug Disposition. 43(2). 66–75. 5 indexed citations

10.

Witkin, Jeffrey M., Rok Cerne, Amy Hauck Newman, et al.. (2021). N-Substituted-3-alkoxy-derivatives of dextromethorphan are functional NMDA receptor antagonists in vivo: Evidence from an NMDA-induced seizure model in rats. Pharmacology Biochemistry and Behavior. 203. 173154–173154. 3 indexed citations

11.

Knutson, Daniel E., Jodi L. Smith, Xingjie Ping, et al.. (2020). Imidazodiazepine Anticonvulsant, KRM-II-81, Produces Novel, Non-diazepam-like Antiseizure Effects. ACS Chemical Neuroscience. 11(17). 2624–2637. 11 indexed citations

12.

Biggerstaff, Andrew, Bronwyn M. Kivell, Jodi L. Smith, et al.. (2020). The α2,3-selective potentiators of GABAA receptors, KRM-II-81 and MP-III-80, produce anxiolytic-like effects and block chemotherapy-induced hyperalgesia in mice without tolerance development. Pharmacology Biochemistry and Behavior. 196. 172996–172996. 12 indexed citations

13.

Cerne, Rok, Scott D. Gleason, Jeffrey M. Schkeryantz, et al.. (2018). An antidepressant-related pharmacological signature for positive allosteric modulators of α2/3-containing GABA A receptors. Pharmacology Biochemistry and Behavior. 170. 9–13. 12 indexed citations

14.

Ma, Wenzhen, Xingjuan Chen, Rok Cerne, et al.. (2018). Catechol estrogens stimulate insulin secretion in pancreatic β-cells via activation of the transient receptor potential A1 (TRPA1) channel. Journal of Biological Chemistry. 294(8). 2935–5880. 18 indexed citations

15.

Witkin, Jeffrey M., Rok Cerne, Mark Wakulchik, et al.. (2017). Further evaluation of the potential anxiolytic activity of imidazo[1,5- a ][1,4]diazepin agents selective for α2/3-containing GABA A receptors. Pharmacology Biochemistry and Behavior. 157. 35–40. 17 indexed citations

16.

Cerne, Rok, Mark Wakulchik, Michael J. Krambis, Kevin D. Burris, & Birgit T. Priest. (2016). IonWorks Barracuda Assay for Assessment of State-Dependent Sodium Channel Modulators. Assay and Drug Development Technologies. 14(2). 84–92. 3 indexed citations

17.

Cerne, Rok, Mark Wakulchik, Baolin Li, Kevin D. Burris, & Birgit T. Priest. (2015). Optimization of a High-Throughput Assay for Calcium Channel Modulators on IonWorks Barracuda. Assay and Drug Development Technologies. 14(2). 75–83. 2 indexed citations

18.

Cerne, Rok, et al.. (2010). Overexpression of Human Transient Receptor Potential M5 Upregulates Endogenous Human Transient Receptor Potential A1 in a Stable HEK Cell Line. Assay and Drug Development Technologies. 8(6). 695–702. 4 indexed citations

19.

Palmer, R. Kyle, Karnail S. Atwal, Rok Cerne, et al.. (2010). Triphenylphosphine Oxide Is a Potent and Selective Inhibitor of the Transient Receptor Potential Melastatin-5 Ion Channel. Assay and Drug Development Technologies. 8(6). 703–713. 60 indexed citations

20.

Qian, Yang, et al.. (2008). Thymol and related alkyl phenols activate the hTRPA1 channel. British Journal of Pharmacology. 153(8). 1739–1749. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact